Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI

Clinical development updates with [68Ga]FAPI-46 and [18F]FAPI-74

Sherly Mosessian, Bridget Adams, Bernadette Omote and Frank Valla
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P230;
Sherly Mosessian
1SOFIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bridget Adams
1SOFIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Omote
1SOFIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Valla
1SOFIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P230

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Sherly Mosessian,
  2. Bridget Adams,
  3. Bernadette Omote and
  4. Frank Valla
  1. 1SOFIE

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023200
Sep 20233400
Oct 20233800
Nov 20235200
Dec 20233500
Jan 20246900
Feb 20244900
Mar 20244700
Apr 202411700
May 20245800
Jun 20245900
Jul 202415100
Aug 202412900
Sep 20245200
Oct 20246300
Nov 20245000
Dec 20247100
Jan 20255400
Feb 20254800
Mar 20254200
Apr 20256500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical development updates with [68Ga]FAPI-46 and [18F]FAPI-74
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical development updates with [68Ga]FAPI-46 and [18F]FAPI-74
Sherly Mosessian, Bridget Adams, Bernadette Omote, Frank Valla
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P230;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical development updates with [68Ga]FAPI-46 and [18F]FAPI-74
Sherly Mosessian, Bridget Adams, Bernadette Omote, Frank Valla
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P230;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Liquid biopsy profiles and 18F-fluorocholine PET/CT in patients receiving immunotherapy-based treatment for advanced unresectable hepatocellular carcinoma
  • Clinical development updates with [18F]FAPI-74
  • Correlation of FDG and FPSG PET parameters with sarcopenia and overall survival in patients with pancreatic ductal adenocarcinoma
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire